2021
DOI: 10.1007/s10875-021-01111-6
|View full text |Cite
|
Sign up to set email alerts
|

Perceptions Around Lung Transplant–Associated Hypogammaglobulinemia

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2022
2022

Publication Types

Select...
1

Relationship

1
0

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 5 publications
0
1
0
Order By: Relevance
“…35 In limited case series/reports, SCIG was well tolerated and efficacious at increasing IgG levels or preventing infections in 10 LT recipients and 1 HT recipient with SHG. 44,45 Insurance has been cited as a barrier to initiating IgG-RT in LT patients with SHG, 291 and it must be noted that both IVIG and SCIG are currently not FDA-approved for post-SOT SHG.…”
Section: Discussionmentioning
confidence: 99%
“…35 In limited case series/reports, SCIG was well tolerated and efficacious at increasing IgG levels or preventing infections in 10 LT recipients and 1 HT recipient with SHG. 44,45 Insurance has been cited as a barrier to initiating IgG-RT in LT patients with SHG, 291 and it must be noted that both IVIG and SCIG are currently not FDA-approved for post-SOT SHG.…”
Section: Discussionmentioning
confidence: 99%